Related Experiment Video
Updated: May 27, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Hypnic headache: clinical course and treatment
Hans-Christoph Diener1, Mark Obermann, Dagny Holle
1Department of Neurology and Westgerman Headache Center Essen, University of Duisburg-Essen, Hufelandstr. 55, 45122, Essen, Germany, hans.diener@uni-duisburg-essen.de.
Current Treatment Options in Neurology
|November 11, 2011
Summary
Caffeine is the recommended first-line treatment for hypnic headache, offering acute relief and prophylaxis. While generally well-tolerated, potential sleep disturbances are a noted side effect, with other medications considered for refractory cases.
Area of Science:
- Neurology
- Pharmacology
Background:
- Hypnic headache treatment lacks randomized controlled trials.
- Current recommendations rely on case reports and series.
- Patient population often elderly, emphasizing tolerability.
Purpose of the Study:
- To review current treatment options for hypnic headache.
- To highlight the importance of tolerability in treatment selection.
- To provide evidence-based recommendations for acute and prophylactic therapies.
Main Methods:
- Review of existing literature and case reports.
- Analysis of treatment efficacy and side effect profiles.
- Consideration of patient population characteristics.
Main Results:
- Caffeine is the preferred first-line therapy for acute treatment and prophylaxis.
- Analgesics with caffeine are effective for acute treatment but risk medication-overuse headache.
- NSAIDs, opioids, oxygen, and acetaminophen are generally ineffective for acute relief.
- Triptans show potential in individual cases.
- Lithium is a second-line prophylactic option, despite potential side effects.
- Indomethacin is a third-line prophylactic choice.
Conclusions:
- Caffeine offers a viable first-line treatment for hypnic headache, balancing efficacy and tolerability.
- Alternative treatments like lithium and indomethacin should be considered for refractory or intolerant patients.
- Further randomized controlled trials are needed to establish definitive treatment guidelines.
Related Concept Videos
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:07Narcolepsy
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
01:23Sedatives and Hypnotics: Overview
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
01:27Insomnia
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
01:20Sedatives and Hypnotics Drugs: Barbiturates
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...
01:14CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...